Bayfortas intramuscular injection 50mg syringe, from AstraZeneca, contains nirsevimab (genetical recombination) and is used to prevent serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in neonates and infants. It comes as 50mg 0.5mL 1 tube, YJ code 6250411G1022.
Bayfortas intramuscular injection 50mg syringe
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →